Siponimod (BAF312) prevents synaptic neurodegeneration in experimental multiple sclerosisInterleukin-23-Induced Transcription Factor Blimp-1 Promotes Pathogenicity of T Helper 17 Cells (2)
Siponimod (BAF312) prevents synaptic neurodegeneration in experimental multiple sclerosis. Gentile et al. J Neuroinflammation.; August 2016 BACKGROUND: Data from multiple sclerosis (MS) and the MS rodent The following content is accessible for members only, please sign in.